Our strategy, priorities, structure, research and development, leadership, and awards and recognition, as well as our commitment to healthcare reform, policy dialogue and responsible business practices.
Our Strategy and Priorities
At Novartis, we are united by a single purpose to reimagine medicine to improve and extend people’s lives.
Our Country Leadership Team
Novartis US is led by the Country Leadership Team (CLT) which includes the US Division CEOs and Country Heads of the key functions responsible for identifying cross-divisional collaboration synergies and driving alignment on corporate matters.
Our Products and Reach
Novartis develops and produces medicines to address patient needs in disease areas where our experience and knowledge have the greatest potential to improve patient outcomes.
Research and Development
In 2019, Novartis invested USD 3.9 billion in US-based research and development (R&D), representing more than 41% of our global R&D spend of USD 9.4 billion.
Value and Pricing
At Novartis, we are pushing the boundaries of science to reimagine medicine and bring the benefits of transformative innovation to patients everywhere.
Responsible Business Practices
At Novartis, we are committed to responsible business practices across our company.
Shaping our Healthcare Environment
Novartis provides healthcare solutions that address the evolving needs of patients and societies worldwide.
Awards & Recognition
Novartis is honored to receive numerous awards for our progress in research and development, our working environment and our corporate responsibility activities.